A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Cancer Research UK
Cancer Research UK
Hoffmann-La Roche